Glarea lozoyensis is an anamorphic ascomycete that produces pneumocandin B0, the starting molecule for the synthesis of the antifungal drug caspofungin (CANCIDAS™). Glarea lozoyensis was first isolated in 1985 from a water sample from Madrid, Spain. Until now, only the original strain was known, but we have discovered new strains from Argentina and the USA. Molecular phylogenetic reference to a 28S rDNA database of antibiotic-producing fungi quickly identified these strains as being conspecific with G. lozoyensis. Bayesian inference phylogeny of ITS, 28S rDNA and α-actin gene fragments revealed that G. lozoyensis is related to species of the genus Cyathicula (Helotiales). Glarea lozoyensis was not conspecific with any of the Cyathicula species sequenced, although it appears to share a common ancestor. Glarea lozoyensis and Cyathicula strains were fermented on nutritional microarrays in 96-well plates. Cyathicula extracts did not show antifungal activity and did not produce pneumocandins, whereas potent antifungal activity and pneumocandin A0 production were confirmed for the four G. lozoyensis isolates. Also, culture morphology differed, with G. lozoyensis strains producing a dark brown, profusely sporulating mycelium with pigmented multicellular conidia accumulating in conidial masses, while all Cyathicula species tested in culture formed hyaline to light brown mycelia and lacked conidia. The chemistry and taxonomic distribution of the echinocandin class of antifungals is comprehensively reviewed.
Baral HO. 1989. Beiträge zur Taxonomie der Discomyceten Ⅱ. Die Calycellina-Arten mit 4sporigen Asci. Beiträge zur Kenntnis der Pilze Mitteleuropas 5: 209–236.
Baral HO. 1992. Vital versus herbarium taxonomy: morphological differences between living and dead cells of Ascomycetes, and their taxonomic implications. Mycotaxon 44: 333–390.
Baral HO. 1994. Comments on “Outline of the ascomycetes - 1993”. Systema Ascomycetum 13: 113–128.
Baral HO. 2002. Tapesina griseovitellina, a rarely reported discomycete, and its anamorph Chalara rubi. Z Mykol. 68: 117–134.
Benz F, Knüsel F, Nüesc J, Treichler H, Voser W, Nyfeler R, Keller-Schierlein W. 1974. Stoffwechselprodukte von Mikroorganismen. Echinocandin B, ein neuartiges Polypetid-Antibioticum aus Aspergillus nidulans var. echinulatus: Isolierung und Bausteine. Helv Chim Acta 57: 2459–2477.
Bills GF, Platas G, Peláez F, Masurekar P. 1999. Reclassification of a pneumocandin-producing anamorph, Glarea lozoyensis gen. et sp. nov., previously identified as Zalerion arboricola. Mycol Res. 103: 179–192.
Bills GF, Platas G, Fillola A, Jiménez R, Collado J, Vicente MF, Martín J, González del Val A, Bur-Zimmerman J, Tormo JR, Peláez F. 2008. Enhancement of antibiotic and secondary metabolite detection from filamentous fungi by growth on nutritional arrays. J Appl Microbiol. 104: 1644–1658.
Bills GF, Martín J, Collado J, Platas G, Overy D, Tormo JR, Vicente F, Verkley G, Crous PW. 2009. Measuring the distribution and diversity of antibiosis and secondary metabolites in the filamentous fungi. Soc Ind Microbiol News 59: 133–146.
Cai L, Wu W-P, Hyde KD. 2009. Phylogenetic relationships of Chalara and allied species inferred from ribosomal DNA sequences. Mycol Prog. 8: 133–143.
Campbell J, Volkmann-Kohlmeyer B, Grafenhan T, Spatafora JW, Kohlmeyer J. 2005. A re-evaluation of Lulworthiales: relationships based on 18S and 28S rDNA. Mycol Res. 109: 556–568.
Carbone I, Kohn LM. 1999. A method for designing primer sets for speciation studies in filamentous Ascomycetes. Mycologia 91: 553–556.
Carpenter SE. 1981. Monograph of Crocicreas (Ascomycetes, Helotiales, Leotiaceae). Mem New York Bot Garden 33: 1–290.
Collado J, Platas G, Paulus B, Bills GF. 2007. High-throughput culturing of fungi from plant litter by a dilution-to-extinction technique. FEMS Microbiol Ecol. 60: 521–533.
Dixon JR. 1974. Chlorosplenium and its segregates. Ⅰ. Introduction and the genus Chlorosplenium. Mycotaxon 1: 65–104.
Dreyfuss MM. 1986. Neue Erkenntnisse aus einem pharmakologischen Pilz-Screening. Sydowia 39: 22–36.
Gams W, Philippi S. 1992. A study of Cyathicula strobilina and its Chalara anamorph in vitro. Persoonia 14: 547–552.
Hennequin S, Ebihara A, Ito M, Iwatsuki K, Dubuisson JY. 2003. Molecular systematics of the fern genus Hymenophyllum s.l. (Hymenophyllaceae) based on chloroplastic coding and noncoding regions. Mol Phylogen Evol. 27: 283–301.
Hino M., Fujie A, Iwamoto T, Hori Y, Hashimoto M, Tsurumi Y, Sakamoto K, Takase S, Hashimoto S. 2001. Chemical diversity in lipopeptide antifungal antibiotics. J Ind Microbiol Biotechnol. 27: 157–162.
Hosoya T, Huhtinen S. 2002. Hyaloscyphaceae in Japan (7): Hyaloscypha albohyalina var. monodictys var. nov. Mycoscience 43: 405–409.
Huhtinen S. 1989. A monograph of Hyaloscypha and allied genera. Karstenia 29: 45–252.
Iturriaga T, Korf RP, Babcock JF. 1999. Fungi on Epifagus Crocicreas epifagicola sp. nov., with comments on the generic names Crocicreas and Cyathicula. Mycol Res. 103: 28–30.
Iwamoto T, Fujie A, Sakamoto K, Tsurumi T, Shigematsu N, Yamashita M, Hashimoto S, Okuhara M, Kohsaka M. 1994. WF11899A, WF11899B and WF11899C, novel antifungal lipopeptides. 1. Taxonomy, fermentation, isolation and physicochemical properties. J Antibiot. 47: 1084–1091.
Joseph JM, Kim R, Reboli AC. 2008. Anidulafungin: a drug evaluation of a new echinocandin. Expert Opin Pharmacother. 9: 2339–2348.
Kanasaki R, Sakamoto K, Hashimoto M, Takase S, Tsurumi Y, Fujie A, Hino M, Hashimoto S, Hori Y. 2006a. FR209602 and related compounds, novel antifungal lipopeptides from Coleophoma crateriformis no.738 - Ⅰ. Taxonomy, fermentation, isolation and physico-chemical properties. J Antibiot. 59: 137–144.
Kanasaki R, Abe F, Kobayashi M, Katsuoka M, Hashimoto M, Takase S, Tsurumi Y, Fujie A, Hino M, Hashimoto S, Hori Y. 2006b. FR220897 and FR22089, novel antifungal lipopeptides from Coelophoma empetri No. 14573. J Antibiot. 59: 149–157.
Kanasaki R, Kobayashi M, Fujine K, Sato I, Hashimoto M, Takase S, Tsurumi Y., Fujie A, Hino M, Hashimoto S, Hori Y. 2006c. FR227673 and FR190293, novel antifungal lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616. J Antibiot. 59: 158–167.
Keller-Juslén C, Kuhn M, Loosli HR, Petcher TJ, Weber HP, von Wartburg A. 1976. Struktur des cyclopeptide –antibiotikums SL 7810 (=Echinochandin B). Tetrahedron Lett. 46: 4147–4150.
Kowalski S, Holdenrieder O. 2009. The teleomorph of Chalara fraxinea, the causal agent of ash dieback. For Pathol. 39: 1–7.
Larena I, Salazar O, González V, Julián MC, Rubio V, 1999. Design of a primer for ribosomal DNA internal transcribed spacer with enhanced specificity for ascomycetes. J Biotechnol. 75: 187–194.
McCormack PL, Perry CM. 2005. Caspofungin. A review of its use in the treatment of fungal infections. Drugs 65: 2049–2068.
Mizuno K, Yagi A, Satoi S, Takada M, Hayashi M, Asano K, Matsuda T. 1977. Studies on aculeacin. Ⅰ. Isolation and characterization of aculeacin A. J Antibiot. 30: 297–302.
Morrison, V. 2006. Echinocandin antifungals: review and update. Expert Rev Anti-infect Ther. 4: 325–342.
Mukhopadhyay T, Roy K, Bhat RG, Sawant SN, Blumbach J, Ganguli BN. 1992. Deoxymulundocandin–a new echinocandin type antifungal antibiotic. J Antibiot. 45: 618–623.
Nakagiri A. 1984. Two new species of Lulworthia and evaluation of genera-delimiting characters between Lulworthia and Lindra (Halosphaeriaceae). Trans Mycol Soc Jpn. 25: 377–388.
Noble HM, Langley D, Sidebottom PJ, Lane SJ, Fisher PJ. 1991. An echinocandin from an endophytic Cryptosporiopsis and Pezicula sp. in Pinus sylvestris and Fagus sylvatica. Mycol Res. 95: 1439–1440.
Peláez F, Platas G, Collado J, Díez MT. 1996. Infraspecific variation in two species of aquatic hyphomycetes, assessed by RAPD analysis. Mycol Res. 100: 831–837.
Petersen LA, Hughes DL, Hughes R, Di Michele L, Salmon P, Connors N. 2001. Effects of amino acid and trace element supplementation on pneumocandin production by Glarea lozoyensis: impact on titer, analogue levels, and the identification of new analogues of pneumocandin B0. J Ind Microbiol Biotechnol. 26: 216–221.
Ronquist F, Huelsenbeck JP, 2003. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19: 1572–1574.
Roy K, Mukhopadhyay T, Reddy GCS, Desikan KR, Ganguli BN. 1987. Mulundocandin, a new lipopeptide antibiotic. Ⅰ. Taxonomy, fermentation, isolation and characterization. J Antibiot. 40: 275–280.
Sánchez Márquez S., Bills GF, Domínguez A, Zabalgogeazcoa I. 2010. Endophytic mycobiota of leaves and roots of the grass Holcus lanatus. Fung Divers. 41:115–123.
Satoi S, Yagi A, Asano K, Mizuno K, Watanabe T. 1977. Studies on aculeacin. Ⅱ. Isolation and characterization of aculeacins B, C, D, E, F and G. J Antibiot. 30: 303–307
Schwartz RE, Giacobbe RA, Bland JA, Monaghan RL. 1989. L-671,329, a new antifungal agent. Ⅰ. Fermentation and isolation. J Antibiot. 42: 163–167.
Schwartz RE, Sesin DF, Joshua H, Wilson KE, Kempf AJ, Goklen KA, Kuehner D, Gailliot P, Gleason C, White R, Inamine E, Bills G, Samon P, Zitano L. 1992. Pneumocandins from Zalerion arboricola. Ⅰ. Discovery and isolation. J Antibiot. 45: 1853–1866.
Strobel GA, Miller RV, Martinez-Miller C, Condron MM, Teplow DB, Hess WM. 1999. Cryptocandin, a potent antimycotic from the endophytic fungus Cryptosporiopsis cf. quercina. Microbiology 145:1919–1926.
Traber R, Keller-Juslén C, Loosli H-R, Kuhn M, von Wartburg A. 1979. Cyclopeptid-Antibiotika aus Aspergillus-Arten. Struktur der Echinocandin C und D. Helv Chim Acta 62:1252–1267.
Triebel D, Baral HO, 1996. Notes on the ascus types in Crocicreas (Leotiales) with a characterization of selected taxa. Sendtnera 3: 199–218.
Vicente F, Basilio A, Platas G, Collado J, Bills GF, González del Val A, Martín J, Tormo JR, Harris GH, Zink DL, Justice M, Nielsen Kahn J, Peláez F. 2009. Distribution of the antifungal agents sordarins across filamentous fungi. Mycol Res. 113: 754–770.
Wiederhold NP, Lewis JS. 2007. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety. Expert Opin Pharmacother. 8: 1155–1166.
Young ND, Healy J, 2003. GapCode automates the use of indel characters in phylogenetic analysis. BMC Bioinformatics 4: 6